Eterna Therapeutics Inc. (ERNAW) — S-1 Filings

All S-1 filings from Eterna Therapeutics Inc.. Browse 1 IPO Filing reports with AI-powered summaries and risk analysis.

S-1 Filings (1)

  • Eterna Therapeutics Files S-1 with SEC — Nov 5, 2024 Risk: medium
    Eterna Therapeutics Inc. filed an S-1 registration statement with the SEC on November 5, 2024. The company, formerly known as Brooklyn ImmunoTherapeutics, Inc.,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.